...
首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Changes in hypertension treatment and in congestive heart failure mortality in the United States.
【24h】

Changes in hypertension treatment and in congestive heart failure mortality in the United States.

机译:美国高血压治疗和充血性心力衰竭死亡率的变化。

获取原文
           

摘要

The use of antihypertensive agents has increased in recent years and has been more marked among individuals in older age groups (65-74 years) than in middle-aged groups (45-54 years). Because hypertension is a strong risk factor for the development of congestive heart failure, more common use of antihypertensive agents would be expected to reduce the incidence of congestive heart failure. Examination of the national death statistics reveals decreases in congestive heart failure mortality at younger ages with mortality increases at older ages. The reasons for these divergent trends in congestive heart failure mortality in different ages and the apparent inconsistency with respect to the changes in the use of antihypertensive drugs are explored. We speculate that antihypertensive treatment does not completely prevent congestive heart failure but merely postpones its development by several decades.
机译:近年来,抗高血压药的使用有所增加,并且在中老年人组(65-74岁)中,其使用情况比中年组(45-54岁)中更为明显。由于高血压是导致充血性心力衰竭的重要危险因素,因此,更常见的使用降压药可降低充血性心力衰竭的发生率。对国家死亡统计数据的检查显示,年轻时充血性心力衰竭死亡率降低,而老龄时死亡率升高。探讨了不同年龄时充血性心力衰竭死亡率差异趋势的原因,以及降压药使用变化方面明显不一致的原因。我们推测降压治疗不能完全预防充血性心力衰竭,而只能将其发展推迟数十年。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号